{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:25:49Z","timestamp":1779110749223,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41433-025-04151-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:41:43Z","timestamp":1764841303000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of intestinal complications, extraintestinal morbidity, and mortality in patients with ulcerative colitis and ocular involvement"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1707-6899","authenticated-orcid":false,"given":"Brian K.","family":"Do","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer F.","family":"Alsoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euna","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan A.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan H.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Kossler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithvi","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-7078","authenticated-orcid":false,"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"4151_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110\u20139. https:\/\/doi.org\/10.1038\/ajg.2010.343.","journal-title":"Am J Gastroenterol"},{"key":"4151_CR2","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:1982\u201392. https:\/\/doi.org\/10.1097\/MIB.0000000000000392.","journal-title":"Inflamm Bowel Dis"},{"key":"4151_CR3","first-page":"173","volume":"24","author":"PV Voulgari","year":"2011","unstructured":"Voulgari PV. Rheumatological manifestations in inflammatory bowel disease. Ann Gastroenterol. 2011;24:173\u201380.","journal-title":"Ann Gastroenterol"},{"key":"4151_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0016-5085(00)70209-5","volume":"118","author":"TR Orchard","year":"2000","unstructured":"Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology. 2000;118:274\u20138. https:\/\/doi.org\/10.1016\/s0016-5085(00)70209-5.","journal-title":"Gastroenterology"},{"key":"4151_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5223\/pghn.2020.23.3.297","volume":"23","author":"DR Kim","year":"2020","unstructured":"Kim DR, Kim D, Choi S, Suh YL, Yoo SY, Kim MJ, et al. Myositis as an initial presentation of ulcerative colitis before gastrointestinal symptoms. Pediatr Gastroenterol Hepatol Nutr. 2020;23:297\u2013303. https:\/\/doi.org\/10.5223\/pghn.2020.23.3.297.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"4151_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67:1298\u2013323. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.022.","journal-title":"J Hepatol"},{"key":"4151_CR7","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus","year":"2004","unstructured":"Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504\u201317. https:\/\/doi.org\/10.1053\/j.gastro.2004.01.063.","journal-title":"Gastroenterology"},{"key":"4151_CR8","doi-asserted-by":"publisher","first-page":"e56944","DOI":"10.1371\/journal.pone.0056944","volume":"8","author":"SL Kristensen","year":"2013","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study. PloS One. 2013;8:e56944 https:\/\/doi.org\/10.1371\/journal.pone.0056944.","journal-title":"PloS One"},{"key":"4151_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet Lond Engl. 2010;375:657\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(09)61963-2.","journal-title":"Lancet Lond Engl"},{"key":"4151_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161:1118\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.042.","journal-title":"Gastroenterology"},{"key":"4151_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ibd.20584","volume":"15","author":"T Felekis","year":"2009","unstructured":"Felekis T, Katsanos K, Kitsanou M, Trakos N, Theopistos V, Christodoulou D, et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis. 2009;15:29\u201334. https:\/\/doi.org\/10.1002\/ibd.20584.","journal-title":"Inflamm Bowel Dis"},{"key":"4151_CR12","doi-asserted-by":"publisher","unstructured":"Glover K, Mishra D, Singh TRR. Epidemiology of ocular manifestations in autoimmune disease. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.744396","DOI":"10.3389\/fimmu.2021.744396"},{"key":"4151_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2007.01.033.","journal-title":"Am J Ophthalmol"},{"key":"4151_CR14","doi-asserted-by":"publisher","first-page":"17463","DOI":"10.3748\/wjg.v20.i46.17463","volume":"20","author":"M Zippi","year":"2014","unstructured":"Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol WJG. 2014;20:17463\u20137. https:\/\/doi.org\/10.3748\/wjg.v20.i46.17463.","journal-title":"World J Gastroenterol WJG"},{"key":"4151_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3\u201325. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw168.","journal-title":"J Crohns Colitis"},{"key":"4151_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384\u2013413. https:\/\/doi.org\/10.14309\/ajg.0000000000000152.","journal-title":"Am J Gastroenterol"},{"key":"4151_CR17","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/ibd\/izaa359","volume":"27","author":"J Shah","year":"2021","unstructured":"Shah J, Shah A, Hassman L, Gutierrez A. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2021;27:1832\u20138. https:\/\/doi.org\/10.1093\/ibd\/izaa359.","journal-title":"Inflamm Bowel Dis"},{"key":"4151_CR18","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6:ooad035 https:\/\/doi.org\/10.1093\/jamiaopen\/ooad035.","journal-title":"JAMIA Open"},{"key":"4151_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806\u20138. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD.","journal-title":"BMJ"},{"key":"4151_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR ROSENBAUM","year":"1983","unstructured":"ROSENBAUM PR, RUBIN DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355. https:\/\/doi.org\/10.1093\/biomet\/70.1.41.","journal-title":"Biometrika"},{"key":"4151_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/jcm10020364","volume":"10","author":"E Antonelli","year":"2021","unstructured":"Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, et al. Dermatological manifestations in inflammatory bowel diseases. J Clin Med. 2021;10:364 https:\/\/doi.org\/10.3390\/jcm10020364.","journal-title":"J Clin Med"},{"key":"4151_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MIB.0000000000000582","volume":"22","author":"\u00d8 Hovde","year":"2016","unstructured":"Hovde \u00d8, Sm\u00e5stuen MC, H\u00f8ivik ML, Bernklev T, Huppertz-Hauss G, H\u00f8ie O, et al. Mortality and causes of death in ulcerative colitis: results from 20 years of follow-up in the IBSEN Study. Inflamm Bowel Dis. 2016;22:141\u20135. https:\/\/doi.org\/10.1097\/MIB.0000000000000582.","journal-title":"Inflamm Bowel Dis"},{"key":"4151_CR23","first-page":"32","volume":"18","author":"GR Lichtenstein","year":"2022","unstructured":"Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, et al. Increased lifetime risk of intestinal complications and extraintestinal manifestations in Crohn\u2019s disease and ulcerative colitis. Gastroenterol Hepatol. 2022;18:32\u201343.","journal-title":"Gastroenterol Hepatol"},{"key":"4151_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MPG.0b013e3181ca4db4","volume":"51","author":"JL Dotson","year":"2010","unstructured":"Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010;51:140\u20135. https:\/\/doi.org\/10.1097\/MPG.0b013e3181ca4db4.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4151_CR25","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.3748\/wjg.v17.i22.2702","volume":"17","author":"FT Veloso","year":"2011","unstructured":"Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?. World J Gastroenterol. 2011;17:2702\u20137. https:\/\/doi.org\/10.3748\/wjg.v17.i22.2702.","journal-title":"World J Gastroenterol"},{"key":"4151_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","volume":"10","author":"K Karmiris","year":"2016","unstructured":"Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:429\u201336. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv232.","journal-title":"J Crohns Colitis"},{"key":"4151_CR27","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.3748\/wjg.v25.i37.5676","volume":"25","author":"S Magr\u00ec","year":"2019","unstructured":"Magr\u00ec S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, et al. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: beyond the natural history. World J Gastroenterol. 2019;25:5676\u201386. https:\/\/doi.org\/10.3748\/wjg.v25.i37.5676.","journal-title":"World J Gastroenterol"},{"key":"4151_CR28","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.3390\/nu13114008","volume":"13","author":"D Mahadea","year":"2021","unstructured":"Mahadea D, Adamczewska E, Ratajczak AE, Rychter AM, Zawada A, Eder P, et al. Iron deficiency anemia in inflammatory bowel diseases\u2014a narrative review. Nutrients. 2021;13:4008 https:\/\/doi.org\/10.3390\/nu13114008.","journal-title":"Nutrients"},{"key":"4151_CR29","first-page":"513","volume":"12","author":"AN Ananthakrishnan","year":"2016","unstructured":"Ananthakrishnan AN. Vitamin D and inflammatory bowel disease. Gastroenterol Hepatol. 2016;12:513\u20135.","journal-title":"Gastroenterol Hepatol"},{"key":"4151_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","volume":"122","author":"T Ali","year":"2009","unstructured":"Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009;122:599\u2013604. https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.022.","journal-title":"Am J Med"},{"key":"4151_CR31","unstructured":"Shahid Z, Brent LH, Lucke M. Enteropathic arthritis. In: StatPearls. StatPearls Publishing; 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594239\/"},{"key":"4151_CR32","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/ibd\/izy354","volume":"25","author":"MS Panhwar","year":"2019","unstructured":"Panhwar MS, Mansoor E, Al-Kindi SG, Sinh P, Katz J, Oliveira GH, et al. Risk of myocardial infarction in inflammatory bowel disease: a Population-based National Study. Inflamm Bowel Dis. 2019;25:1080\u20137. https:\/\/doi.org\/10.1093\/ibd\/izy354.","journal-title":"Inflamm Bowel Dis"},{"key":"4151_CR33","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1212\/WNL.0000000000207480","volume":"101","author":"J Sun","year":"2023","unstructured":"Sun J, Halfvarson J, Appelros P, Bergman D, Ebrahimi F, Roelstraete B, et al. Long-term risk of stroke in patients with inflammatory bowel disease: a Population-Based, Sibling-Controlled Cohort Study, 1969-2019. Neurology. 2023;101:e653\u2013e664. https:\/\/doi.org\/10.1212\/WNL.0000000000207480.","journal-title":"Neurology"},{"key":"4151_CR34","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.jacc.2020.10.027","volume":"76","author":"M Cainzos-Achirica","year":"2020","unstructured":"Cainzos-Achirica M, Glassner K, Zawahir HS, Dey AK, Agrawal T, Quigley EMM, et al. Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2020;76:2895\u2013905. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.027.","journal-title":"J Am Coll Cardiol"},{"key":"4151_CR35","unstructured":"Morbidity and mortality higher in ulcerative colitis patients with infections. 2024. https:\/\/www.hcplive.com\/view\/morbidity-mortality-ulcerative-colitis-infections"},{"key":"4151_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ecco-jcc\/jjv178","volume":"10","author":"S Taleban","year":"2016","unstructured":"Taleban S, Li D, Targan SR, Ippoliti A, Brant SR, Cho JH, et al. Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits. J Crohns Colitis. 2016;10:43\u201349. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv178.","journal-title":"J Crohns Colitis"},{"key":"4151_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2012.01.016","volume":"154","author":"J Abbasian","year":"2012","unstructured":"Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA. Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol. 2012;154:72\u201377. https:\/\/doi.org\/10.1016\/j.ajo.2012.01.016.","journal-title":"Am J Ophthalmol"},{"key":"4151_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.gastro.2024.02.026","volume":"167","author":"M Khrom","year":"2024","unstructured":"Khrom M, Long M, Dube S, Robbins L, Botwin GJ, Yang S, et al. Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease. Gastroenterology. 2024;167:315\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2024.02.026.","journal-title":"Gastroenterology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04151-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04151-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04151-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:37:45Z","timestamp":1769168265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04151-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4151"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04151-z","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PM: Consultant \u2013 Aura Biosciences, Castle Biosciences, Alcon, Genentech; Financial support \u2013 Genentech; Lecturer \u2013 Alcon. BD: Consultant \u2013 Abbvie\/Allergan, Alimera, Annexon Biosciences, ANI Pharmaceuticals, Bausch & Lomb Pharmaceuticals, Bausch & Lomb Surgical, Eyepoint Pharmaceuticals, Genentech, Ocular Therapeutix, Regenerative Patch Technologies; Speaker \u2013 Abbvie\/Allergan, Alimera. ER: Consultant \u2013 Apellis Pharmaceuticals, Iveric Bio, Genentech, Regeneron, Allergan, Zeiss, Google; Speaker \u2013 Apellis Pharmaceuticals, Genentech, Regeneron, Allergan. RM: Consultant \u2013 Pfizer; Speaker \u2013 Eli Lilly, Pfizer, AbbVie, Bristol Myers Squibb, Takeda, Janssen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}